Mitsubishi UFJ Asset Management Co. Ltd. Makes New Investment in MetLife, Inc. $MET

Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of MetLife, Inc. (NYSE:MET - Free Report) during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund purchased 1,323,242 shares of the financial services provider's stock, valued at approximately $111,960,000. Mitsubishi UFJ Asset Management Co. Ltd. owned about 0.21% of MetLife as of its most recent filing with the SEC.

Other hedge funds have also modified their holdings of the company. Vanguard Group Inc. boosted its position in MetLife by 12.1% in the fourth quarter. Vanguard Group Inc. now owns 72,555,335 shares of the financial services provider's stock valued at $5,727,518,000 after buying an additional 7,805,814 shares during the last quarter. Pzena Investment Management LLC raised its position in MetLife by 22.9% during the 4th quarter. Pzena Investment Management LLC now owns 11,883,338 shares of the financial services provider's stock worth $938,071,000 after buying an additional 2,211,315 shares during the last quarter. Norges Bank acquired a new stake in MetLife during the 4th quarter valued at approximately $639,986,000. Invesco Ltd. lifted its stake in MetLife by 2.6% during the 4th quarter. Invesco Ltd. now owns 7,012,198 shares of the financial services provider's stock valued at $553,543,000 after acquiring an additional 176,811 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of MetLife by 2.5% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,201,175 shares of the financial services provider's stock valued at $410,581,000 after acquiring an additional 126,098 shares during the last quarter. 94.99% of the stock is owned by institutional investors and hedge funds.

MetLife Stock Up 0.2%

Shares of MET opened at $96.83 on Wednesday. The firm has a market cap of $62.31 billion, a P/E ratio of 18.55, a PEG ratio of 0.75 and a beta of 0.78. MetLife, Inc. has a 12 month low of $67.33 and a 12 month high of $100.93. The stock's 50 day moving average is $92.00 and its two-hundred day moving average is $81.86. The company has a current ratio of 0.20, a quick ratio of 0.20 and a debt-to-equity ratio of 0.52.

MetLife (NYSE:MET - Get Free Report) last announced its earnings results on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share for the quarter, topping the consensus estimate of $2.30 by $0.13. MetLife had a return on equity of 23.39% and a net margin of 4.57%.The business had revenue of $13.52 billion during the quarter, compared to the consensus estimate of $19.67 billion. During the same period in the prior year, the company posted $2.02 EPS. The business's quarterly revenue was up 10.5% on a year-over-year basis. Analysts predict that MetLife, Inc. will post 9.7 earnings per share for the current fiscal year.

MetLife announced that its board has initiated a stock buyback program on Wednesday, August 5th that permits the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization permits the financial services provider to repurchase up to 4.8% of its stock through open market purchases. Stock repurchase programs are often an indication that the company's management believes its stock is undervalued.

MetLife Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 8th. Stockholders of record on Tuesday, August 4th will be paid a dividend of $0.5925 per share. The ex-dividend date of this dividend is Tuesday, August 4th. This represents a $2.37 dividend on an annualized basis and a dividend yield of 2.4%. MetLife's payout ratio is currently 45.40%.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on MET. Wells Fargo & Company raised their target price on shares of MetLife from $95.00 to $101.00 and gave the stock an "overweight" rating in a report on Thursday, July 9th. Mizuho upped their price target on shares of MetLife from $95.00 to $102.00 and gave the company an "outperform" rating in a report on Thursday, July 9th. Piper Sandler increased their price target on MetLife from $86.00 to $90.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 24th. JPMorgan Chase & Co. lifted their price objective on MetLife from $106.00 to $108.00 and gave the company an "overweight" rating in a research note on Tuesday, August 11th. Finally, Barclays boosted their price objective on MetLife from $94.00 to $97.00 and gave the company an "overweight" rating in a report on Thursday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $101.07.

Trending Headlines about MetLife

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: DOWLING & PARTN raised its fiscal 2027 earnings estimate for MetLife to $10.85 per share from $10.75. The revision suggests improving analyst expectations for the insurer’s future profitability and is favorable for MET, although the new estimate remains above the broader current-year consensus of $9.70. MetLife FY2027 earnings estimate
• Neutral Sentiment: MetLife declared third-quarter 2026 dividends on several series of preferred stock, including Series A, Series D, Series E and Series F. The payments reinforce the company’s ongoing capital-return commitments, but they primarily affect preferred shareholders and are unlikely to materially change the valuation of MET common shares. MetLife preferred stock dividends
• Neutral Sentiment: MetLife published its 2025 sustainability report, highlighting research and insights related to its environmental, social and governance initiatives. The report may support the company’s long-term reputation with stakeholders, but it is not expected to have an immediate earnings impact. MetLife 2025 sustainability report
• Neutral Sentiment: Several headlines concern MetLife Stadium, including a new stadium CEO, rapid transitions between Jets and Giants games, and upcoming concerts. These stories relate to the sports and entertainment venue—not MetLife, Inc.’s insurance and financial-services operations—and should not materially affect MET stock. MetLife Stadium names new CEO

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source